Once-Rejected Drug Now FDA Approved for CKD-Related Anemia
(MedPage Today) -- The FDA approved vadadustat (Vafseo) for chronic kidney disease (CKD)-related anemia in adults who have been on dialysis for at least 3 months, developer Akebia Therapeutics announced on Wednesday.
"Patients receiving maintenance...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Anemia | Cancer & Oncology | Chronic Kidney Disease | Dialysis | Hematology | Urology & Nephrology